Denovo Biopharma Llc
Clinical trials sponsored by Denovo Biopharma Llc, explained in plain language.
-
New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
Disease control Stopped earlyResearchers are testing an experimental drug called LY2140023 in people with schizophrenia who have already completed a short-term trial of the same drug. The study compares LY2140023 to standard antipsychotic medications like olanzapine, aripiprazole, risperidone, and quetiapine…
Phase 2/3 • Sponsor: Denovo Biopharma LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Five-Year safety check for experimental schizophrenia drug
Disease control Stopped earlyResearchers are studying the long-term safety of pomaglumetad methionil, an experimental drug taken by mouth, in adults with schizophrenia. About 129 participants receive the drug and are monitored for up to five years. The study tracks movement side effects, weight, blood sugar,…
Phase 3 • Sponsor: Denovo Biopharma LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC